Drug intelligence / Profile preview

Synerfill Vivid Plus

Development stage
Unknown
Lead developer
Maxcore Global
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intradermal, Subcutaneous
01

Overview

Synerfill Vivid Plus is an injectable skin booster and aesthetic dermatology product developed by Maxcore Global. The formulation is a complex blend of high-molecular-weight and low-molecular-weight hyaluronic acid (HA), polydeoxyribonucleotide (PDRN), polynucleotide (PN), nicotinamide adenine dinucleotide (NAD), glutathione, and recombinant human (RH) collagen. It is designed for facial and body rejuvenation, aiming to improve skin hydration, elasticity, and cellular repair. PDRN and PN components are thought to stimulate tissue regeneration through adenosine receptor activation, while HA provides immediate volume and hydration. Glutathione and NAD provide antioxidant support and cellular energy. The product is manufactured in South Korea and marketed for professional use in aesthetic clinics.

Brand names
Synerfill Vivid PlusMonica Synerfill Vivid Plus
02

Targets

ADORA2A (Adenosine A₂A Receptor)CD44 (CD44 antigen)

Beyond the preview

Go deeper on Synerfill Vivid Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synerfill Vivid Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call